Type Sociedad Anónima Industry Pharmaceutical Products Pharmaceuticals Founded 1939 | Traded as BMAD: ZEL Area served Worldwide Headquarters Spain | |
 | ||
Key people José Fernández Sousa-Faro (Chairman) Stock price PHM (BME) € 2.98 -0.02 (-0.67%)31 Mar, 5:36 PM GMT+2 - Disclaimer Subsidiaries PharmaMar S.r.L, Pharmamar Gmbh Profiles | ||
Zeltia is a Spanish pharmaceutical company which operates through a variety of subsidiaries in the pharmaceutical and chemical industries. As of 2007, Zeltia's research activities in the pharmaceutical area had not resulted in a marketed product. However, the company's majority shareholder and chairman are the same person, which has relieved the pressure which many CEOs have experienced to produce immediate returns.
Subsidiaries
Direct subsidiaries as of 2009 were: Pharma Mar, S.A.U.; Genómica, S.A.U.; Zelnova, S.A; Protección de Maderas, S.A.U; Xylazel, S.A.; Noscira, S.A.; Sylentis, S.A.
Indirect subsidiaries which are direct subsidiaries of Pharma Mar as of 2009 were: Pharma Mar US; Pharma Mar AG; PharmaMar S.A.R.L.; Pharma Mar GmbH; Pharma Mar Ltd.
A single indirect subsidiary is a direct subsidiary of Zelnova, that being Copyr, S.p.A.